Q&A: PhRMA CEO Stephen Ubl on the IRA, chal­lenges to the FDA’s au­thor­i­ty and the US-Chi­na re­la­tion­ship

As we ap­proach the 2024 pres­i­den­tial elec­tion, Stephen Ubl, pres­i­dent and CEO of the phar­ma­ceu­ti­cal in­dus­try’s DC-based trade group PhRMA, said “the po­lit­i­cal process has …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER